These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

520 related articles for article (PubMed ID: 22179221)

  • 21. Activation of PPARβ/δ protects pancreatic β cells from palmitate-induced apoptosis by upregulating the expression of GLP-1 receptor.
    Yang Y; Tong Y; Gong M; Lu Y; Wang C; Zhou M; Yang Q; Mao T; Tong N
    Cell Signal; 2014 Feb; 26(2):268-78. PubMed ID: 24269940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological PPARβ/δ activation upregulates VLDLR in hepatocytes.
    Zarei M; Barroso E; Palomer X; Escolà-Gil JC; Cedó L; Wahli W; Vázquez-Carrera M
    Clin Investig Arterioscler; 2019; 31(3):111-118. PubMed ID: 30987865
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological activation of AMPK suppresses inflammatory response evoked by IL-6 signalling in mouse liver and in human hepatocytes.
    Nerstedt A; Cansby E; Amrutkar M; Smith U; Mahlapuu M
    Mol Cell Endocrinol; 2013 Aug; 375(1-2):68-78. PubMed ID: 23707791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of the mTORC1/STAT3/Notch1 pathway by activated AMPK prevents hepatic insulin resistance induced by excess amino acids.
    Li H; Lee J; He C; Zou MH; Xie Z
    Am J Physiol Endocrinol Metab; 2014 Jan; 306(2):E197-209. PubMed ID: 24302004
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) attenuates carbon tetrachloride hepatotoxicity by downregulating proinflammatory gene expression.
    Shan W; Palkar PS; Murray IA; McDevitt EI; Kennett MJ; Kang BH; Isom HC; Perdew GH; Gonzalez FJ; Peters JM
    Toxicol Sci; 2008 Oct; 105(2):418-28. PubMed ID: 18622026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PPARbeta/delta agonists modulate platelet function via a mechanism involving PPAR receptors and specific association/repression of PKCalpha--brief report.
    Ali FY; Hall MG; Desvergne B; Warner TD; Mitchell JA
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1871-3. PubMed ID: 19696401
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [PPARβ/δ Activation prevents hypertriglyceridemia caused by a high fat diet. Involvement of AMPK and PGC-1α-Lipin1-PPARα pathway].
    Barroso E; Astudillo AM; Balsinde J; Vázquez-Carrera M
    Clin Investig Arterioscler; 2013; 25(2):63-73. PubMed ID: 23849213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMP-activated protein kinase inhibits IL-6-stimulated inflammatory response in human liver cells by suppressing phosphorylation of signal transducer and activator of transcription 3 (STAT3).
    Nerstedt A; Johansson A; Andersson CX; Cansby E; Smith U; Mahlapuu M
    Diabetologia; 2010 Nov; 53(11):2406-16. PubMed ID: 20652679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic tumor necrosis factor-alpha treatment causes insulin resistance via insulin receptor substrate-1 serine phosphorylation and suppressor of cytokine signaling-3 induction in 3T3-L1 adipocytes.
    Ishizuka K; Usui I; Kanatani Y; Bukhari A; He J; Fujisaka S; Yamazaki Y; Suzuki H; Hiratani K; Ishiki M; Iwata M; Urakaze M; Haruta T; Kobayashi M
    Endocrinology; 2007 Jun; 148(6):2994-3003. PubMed ID: 17379643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta) ligands do not potentiate growth of human cancer cell lines.
    Hollingshead HE; Killins RL; Borland MG; Girroir EE; Billin AN; Willson TM; Sharma AK; Amin S; Gonzalez FJ; Peters JM
    Carcinogenesis; 2007 Dec; 28(12):2641-9. PubMed ID: 17693664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARβ/δ Agonist Provides Neuroprotection by Suppression of IRE1α-Caspase-12-Mediated Endoplasmic Reticulum Stress Pathway in the Rotenone Rat Model of Parkinson's Disease.
    Tong Q; Wu L; Gao Q; Ou Z; Zhu D; Zhang Y
    Mol Neurobiol; 2016 Aug; 53(6):3822-3831. PubMed ID: 26160761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-Dependent Interaction of PPARδ With T-Cell Protein Tyrosine Phosphatase 45 Enhances Insulin Signaling.
    Yoo T; Ham SA; Lee WJ; Hwang SI; Park JA; Hwang JS; Hur J; Shin HC; Han SG; Lee CH; Han DW; Paek KS; Seo HG
    Diabetes; 2018 Mar; 67(3):360-371. PubMed ID: 29233935
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A20 promotes liver regeneration by decreasing SOCS3 expression to enhance IL-6/STAT3 proliferative signals.
    da Silva CG; Studer P; Skroch M; Mahiou J; Minussi DC; Peterson CR; Wilson SW; Patel VI; Ma A; Csizmadia E; Ferran C
    Hepatology; 2013 May; 57(5):2014-25. PubMed ID: 23238769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis.
    Piqueras L; Reynolds AR; Hodivala-Dilke KM; Alfranca A; Redondo JM; Hatae T; Tanabe T; Warner TD; Bishop-Bailey D
    Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):63-9. PubMed ID: 17068288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of Cytochrome P450 2B10 (CYP2B10) Expression in Liver by Peroxisome Proliferator-activated Receptor-β/δ Modulation of SP1 Promoter Occupancy.
    Koga T; Yao PL; Goudarzi M; Murray IA; Balandaram G; Gonzalez FJ; Perdew GH; Fornace AJ; Peters JM
    J Biol Chem; 2016 Nov; 291(48):25255-25263. PubMed ID: 27765815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 15-Lipoxygenase-1 suppression of colitis-associated colon cancer through inhibition of the IL-6/STAT3 signaling pathway.
    Mao F; Xu M; Zuo X; Yu J; Xu W; Moussalli MJ; Elias E; Li HS; Watowich SS; Shureiqi I
    FASEB J; 2015 Jun; 29(6):2359-70. PubMed ID: 25713055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated PPARβ/δ Protects Pancreatic β Cells in Type 2 Diabetic Goto-Kakizaki Rats from Lipoapoptosis via GPR40.
    Li J; Xu S; Liu Y; Yan Z; Zhang F; Lv Q; Tong N
    Lipids; 2019 Oct; 54(10):603-616. PubMed ID: 31364177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Apoptotic effect of the selective PPARβ/δ agonist GW501516 in invasive bladder cancer cells.
    Péchery A; Fauconnet S; Bittard H; Lascombe I
    Tumour Biol; 2016 Nov; 37(11):14789-14802. PubMed ID: 27638828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand activation of peroxisome proliferator-activated receptor-beta/delta inhibits cell proliferation in human HaCaT keratinocytes.
    Borland MG; Foreman JE; Girroir EE; Zolfaghari R; Sharma AK; Amin S; Gonzalez FJ; Ross AC; Peters JM
    Mol Pharmacol; 2008 Nov; 74(5):1429-42. PubMed ID: 18687807
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.
    Clementi AH; Gaudy AM; van Rooijen N; Pierce RH; Mooney RA
    Biochim Biophys Acta; 2009 Nov; 1792(11):1062-72. PubMed ID: 19699298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.